Authors: Spencer, T Biederman, J Heiligenstein, J Wilens, T Faries, D Prince, J Faraone, SV Rea, J Witcher, J Zervas, S

Citation: T. Spencer et al., An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder, J CH AD PSY, 11(3), 2001, pp. 251-265

Authors: Michelson, D Faries, D Wernicke, J Kelsey, D Kendrick, K Sallee, FR Spencer, T

Citation: D. Michelson et al., Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study, PEDIATRICS, 108(5), 2001, pp. NIL_33-NIL_41

Authors: Levine, LR Tonneson, P Wennike, P Faries, D

Citation: Lr. Levine et al., Moxonidine versus placebo as an aid in smoking cessation, HUM PSYCHOP, 15(8), 2000, pp. 605-611

Authors: Faries, D Herrera, J Rayamajhi, J DeBrota, D Demitrack, M Potter, WZ

Citation: D. Faries et al., The responsiveness of the Hamilton Depression Rating Scale, J PSYCH RES, 34(1), 2000, pp. 3-10

Authors: Demitrack, MA Faries, D Herrera, JM DeBrota, DJ Potter, WZ

Citation: Ma. Demitrack et al., The problem of measurement error in multisite clinical trials, PSYCHOPH B, 34(1), 1998, pp. 19-24